Sorrento Cleared For $20M JV Sale In Ch. 11 Case
Bankrupt drug developer Sorrento Therapeutics Inc. received court approval Wednesday in Texas for a $20 million sale of its stake in a joint venture to its South Korean partner, giving it...To view the full article, register now.
Already a subscriber? Click here to view full article